Oncolytic Gene Therapy with Recombinant Vaccinia Strain GLV-2b372 Efficiently Kills Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) commonly presents at a late stage when surgery is no longer a curative option. As such, novel therapies for advanced HCC are needed. Oncolytic viruses are a viable option for cancer therapy due to their ability to specifically infect, replicate within, and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Surgery
Autors principals: Ady, Justin W, Johnsen, Clark, Mojica, Kelly, Heffner, Jacqueline, Love, Damon, Pugalenthi, Amudhan, Belin, Laurence J, Chen, Nanhai G., Yu, Yong A., Szalay, Aladar A., Fong, Yuman
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4819004/
https://ncbi.nlm.nih.gov/pubmed/26049609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.surg.2015.03.044
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars